Immunosurveillance
Cancer immunosurveillance is a process by which an organism's immune system recognizes transformed cells in order to inhibit the growth of neoplastic tissue.[1][2] It comprises the first phase of immunoediting and is also known as the elimination phase.[3]
See also
- Cancer immunology
- Cancer_immunology#Immunosurveillance - better than this stub
References
- ↑ "Immunosurveillance". Nature (journal). Retrieved 9 October 2015.
- ↑ Slaney, C. Y.; Rautela, J.; Parker, B. S. (23 September 2013). "The Emerging Role of Immunosurveillance in Dictating Metastatic Spread in Breast Cancer". Cancer Research. 73 (19): 5852–5857. doi:10.1158/0008-5472.CAN-13-1642.
- ↑ Dunn, Gavin P.; Old, Lloyd J.; Schreiber, Robert D. (August 2004). "The Immunobiology of Cancer Immunosurveillance and Immunoediting". Immunity. 21 (2): 137–148. doi:10.1016/j.immuni.2004.07.017. PMID 15308095.
This article is issued from Wikipedia - version of the 6/19/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.